Omnicell, Inc.

OMCL · NasdaqGS · Stock · Healthcare
$35.39
-2.91% today
Delayed price,

What Omnicell does

Omnicell, Inc., together with its subsidiaries, provides healthcare technology in the United States and internationally. It offers hospital and health systems solutions, such as points of care for clinician workflows in patient care areas of the healthcare system; Titan XT, an automated dispensing system; XTExtend, a console swap for its XT cabinets; and Central Pharmacy Dispensing Service for the medication dispensing process. The company also provides Central Med Automation Service for medication dispensing; IV Compounding Service, an in-house compounding system; specialty pharmacy services, including turnkey solution to help health systems establish, manage, and optimize an entity-owned specialty pharmacy; EnlivenHealth platform to digitally enable retail and community pharmacies; medication adherence solutions comprising consumables and medication packaging systems; and technology implementation, customer education and training, program management, and related offerings to professional services. In addition, it offers post-installation support and maintenance via phone and/or web, on-site service, parts, and access to software upgrades; software and hardware products for full traceability of medicines and medical supplies throughout the healthcare system; OmniSphere, a cloud-based platform. The company was formerly known as Omnicell Technologies, Inc. and changed its name to Omnicell, Inc. in 2001. Omnicell, Inc. was incorporated in 1992 and is headquartered in Fort Worth, Texas.

Key facts

Sector
Healthcare
Industry
Health Information Services
Market cap
$1.61B
P/E (ttm)
43.2
Forward P/E
17.2
Dividend yield
0.00%
Beta
0.99
Profit margin
3.1%
Employees
3,485
Headquarters
Fort Worth, TX, United States
Exchange
NasdaqGS

Performance

1 Month
+9.8%
3 Months
-22.8%
6 Months
-7.5%
1 Year
+18.4%
5 Years
-80.0%
$29.0952-week range$55.00
Biggest setback — last 12 months
-36.5%
5 Jan 2026 → 14 Sept 2026
Fell from $50.74 to $32.23 — its sharpest sustained decline this year.
Biggest run-up — last 12 months
+69.7%
13 Oct 2025 → 5 Jan 2026
Ran from $29.90 to $50.74 — its strongest sustained advance this year.

Price outlook — trend & volatility model

● Trend: Below long-term trend
Price sits below its 200-day average, but the shorter-term averages are not cleanly aligned above/below it.
HorizonBear case (−1σ)Base caseBull case (+1σ)
1 Month$30.83 (-12.9%)$35.39$40.62 (+14.8%)
3 Months$27.87 (-21.2%)$35.39$44.94 (+27.0%)
6 Months$25.25 (-28.7%)$35.39$49.61 (+40.2%)
12 Months$21.95 (-38.0%)$35.39$57.05 (+61.2%)
Statistical, not machine-learning: a random-walk (no assumed drift) volatility model built from this ticker's own realized price history, plus a purely descriptive moving-average trend read. Illustrative only — not a price target and not financial advice. The bear and bull cases sit one standard deviation (1σ) below and above today's price, a range that covers about 68% of the outcomes the model treats as plausible, not a 68% chance of either case. Annualized volatility used: 47.8%, blended from this ticker's own 3-month and 1-year realized price history. Base case is deliberately flat — this quantifies a possible range, not a directional prediction. See the full model, including wider (≈95%) bands →

Comparable companies

Recent headlines

Learn the basics

Prices and company data are delayed reference figures from public sources (Yahoo Finance, SEC EDGAR) and may be inaccurate or out of date. This page is informational only — it is not investment advice or a recommendation to buy or sell any security. Past performance does not indicate future results.